This Nonprofit’s Clinical Trial Committee Aims to Help Rett Syndrome Drug Development
source: pixabay.com

This Nonprofit’s Clinical Trial Committee Aims to Help Rett Syndrome Drug Development

According to a story from news-medical.net, the International Rett Syndrome Foundation (IRSF) has announced the launch of its Clinical Trial Committee. The committee was implemented with the goal of helping…

Continue Reading This Nonprofit’s Clinical Trial Committee Aims to Help Rett Syndrome Drug Development

Stoke Therapeutics and Acadia Pharmaceuticals Collaborate to Develop Medicines for Rare Neurodevelopmental Disorders

Stoke Therapeutics and Acadia Pharmaceuticals made a joint announcement this week through Business Wire of their collaboration in the development of RNA-based medicines to potentially treat rare neurodevelopmental disorders of…

Continue Reading Stoke Therapeutics and Acadia Pharmaceuticals Collaborate to Develop Medicines for Rare Neurodevelopmental Disorders
New Genomic DNA Modification in Zebrafish Could Help Us Study Human Disease
https://pixabay.com/photos/danio-rerio-zebrafish-small-fish-4996610/

New Genomic DNA Modification in Zebrafish Could Help Us Study Human Disease

Did you know that zebrafish, a tropical freshwater fish, are being more commonly used to model and study human diseases? Now, says Phys.org, researchers from the Garvan Institute of Medical…

Continue Reading New Genomic DNA Modification in Zebrafish Could Help Us Study Human Disease

Rett Syndrome Treatment TSHA-102 Received Rare Pediatric Disease and Orphan Drug Designations

Recently, gene therapy company Taysha Gene Therapies ("Taysha") announced that its gene therapy candidate, TSHA-102, received both Orphan Drug and Rare Pediatric Disease designations from the FDA. TSHA-102, delivered via…

Continue Reading Rett Syndrome Treatment TSHA-102 Received Rare Pediatric Disease and Orphan Drug Designations